HKD 4.32
(-0.23%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 1.53 Billion HKD | 29.43% |
2022 | 1.18 Billion HKD | -14.79% |
2021 | 1.39 Billion HKD | 75.83% |
2020 | 793.82 Million HKD | -23.18% |
2019 | 1.03 Billion HKD | 6.14% |
2018 | 973.54 Million HKD | 31.99% |
2017 | 737.6 Million HKD | 18.39% |
2016 | 623.02 Million HKD | 17.64% |
2015 | 529.59 Million HKD | 28.77% |
2014 | 411.25 Million HKD | 32.27% |
2013 | 310.93 Million HKD | 27.59% |
2012 | 243.69 Million HKD | 26.63% |
2011 | 192.43 Million HKD | 43.24% |
2010 | 134.34 Million HKD | 27.16% |
2009 | 105.64 Million HKD | 2.98% |
2008 | 102.59 Million HKD | 46.9% |
2007 | 69.83 Million HKD | 43.53% |
2006 | 48.65 Million HKD | 16.79% |
2005 | 41.66 Million HKD | 20.74% |
2004 | 34.5 Million HKD | 76.22% |
2003 | 19.58 Million HKD | -19.05% |
2002 | 24.19 Million HKD | 1.89% |
2001 | 23.74 Million HKD | 27.83% |
2000 | 18.57 Million HKD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 724.61 Million HKD | 0.0% |
2023 Q2 | 810.46 Million HKD | 0.0% |
2023 FY | 1.53 Billion HKD | 29.43% |
2023 Q4 | 728.83 Million HKD | 0.0% |
2022 FY | 1.18 Billion HKD | -14.79% |
2022 Q2 | 586.64 Million HKD | 0.0% |
2022 Q4 | 602.68 Million HKD | 0.0% |
2021 Q2 | 622.69 Million HKD | 0.0% |
2021 FY | 1.39 Billion HKD | 75.83% |
2021 Q4 | 773.07 Million HKD | 0.0% |
2020 Q2 | 254.71 Million HKD | 0.0% |
2020 Q4 | 539.11 Million HKD | 0.0% |
2020 FY | 793.82 Million HKD | -23.18% |
2019 FY | 1.03 Billion HKD | 6.14% |
2019 Q4 | 564.58 Million HKD | 0.0% |
2019 Q2 | 468.76 Million HKD | 0.0% |
2018 Q2 | 459.29 Million HKD | 0.0% |
2018 FY | 973.54 Million HKD | 31.99% |
2018 Q4 | 514.24 Million HKD | 0.0% |
2017 FY | 737.6 Million HKD | 18.39% |
2017 Q4 | 380.04 Million HKD | 0.0% |
2017 Q2 | 357.56 Million HKD | 0.0% |
2016 Q2 | 295.25 Million HKD | 0.0% |
2016 FY | 623.02 Million HKD | 17.64% |
2016 Q4 | 327.77 Million HKD | 0.0% |
2015 Q2 | 256.68 Million HKD | 0.0% |
2015 Q4 | 272.91 Million HKD | 0.0% |
2015 FY | 529.59 Million HKD | 28.77% |
2014 Q4 | 221.36 Million HKD | 0.0% |
2014 Q2 | 189.88 Million HKD | 0.0% |
2014 FY | 411.25 Million HKD | 32.27% |
2013 FY | 310.93 Million HKD | 27.59% |
2013 Q4 | 160.66 Million HKD | 0.0% |
2013 Q2 | 150.27 Million HKD | 0.0% |
2012 FY | 243.69 Million HKD | 26.63% |
2012 Q4 | - HKD | 0.0% |
2012 Q2 | - HKD | 0.0% |
2011 Q2 | - HKD | 0.0% |
2011 Q4 | - HKD | 0.0% |
2011 FY | 192.43 Million HKD | 43.24% |
2010 FY | 134.34 Million HKD | 27.16% |
2010 Q2 | 34.37 Million HKD | 0.0% |
2009 Q2 | 26.45 Million HKD | 0.0% |
2009 FY | 105.64 Million HKD | 2.98% |
2008 FY | 102.59 Million HKD | 46.9% |
2007 FY | 69.83 Million HKD | 43.53% |
2006 FY | 48.65 Million HKD | 16.79% |
2005 FY | 41.66 Million HKD | 20.74% |
2004 FY | 34.5 Million HKD | 76.22% |
2003 FY | 19.58 Million HKD | -19.05% |
2002 FY | 24.19 Million HKD | 1.89% |
2001 FY | 23.74 Million HKD | 27.83% |
2000 FY | 18.57 Million HKD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Pak Fah Yeow International Limited | 167.43 Million HKD | -819.332% |
Grand Pharmaceutical Group Limited | 6.52 Billion HKD | 76.406% |
Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -5248.668% |
Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -289.879% |
Qianhai Health Holdings Limited | -35.6 Million HKD | 4423.493% |
Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -179.206% |
Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -226.611% |
PuraPharm Corporation Limited | 216.62 Million HKD | -610.566% |
SSY Group Limited | 3.48 Billion HKD | 55.884% |
JBM (Healthcare) Limited | 319.41 Million HKD | -381.909% |
Jacobson Pharma Corporation Limited | 620.47 Million HKD | -148.083% |
China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 96.45% |